Related Experiment Video
Updated: Apr 8, 2026

Generation and Expansion of Primary, Malignant Pleural Mesothelioma Tumor Lines
Published on: April 21, 2022
miR-193a-3p is a potential tumor suppressor in malignant pleural mesothelioma
Marissa Williams1, Michaela B Kirschner1,2,3, Yuen Yee Cheng1
1Asbestos Diseases Research Institute (ADRI), Sydney, Australia.
Abstract:
Malignant pleural mesothelioma (MPM) is an asbestos-induced cancer with poor prognosis that displays characteristic alterations in microRNA expression. Recently it was reported that the expression of a subset of microRNAs can distinguish between MPM and adenocarcinoma of the lung. However, the functional importance of these changes has yet to be investigated. We compared expression of miR-192, miR-193a-3p and the miR-200 family in normal pleura and MPM tumor specimens and found a statistically significant reduction in the levels of miR-193a-3p (3.1-fold) and miR-192 (2.8-fold) in MPM. Transfection of MPM cells with a miR-193a-3p mimic resulted in inhibition of growth and an induction of apoptosis and necrosis in vitro. The growth inhibitory effects of miR-193a-3p were associated with a decrease in MCL1 expression and were recapitulated by RNAi-mediated MCL1 silencing. Targeted delivery of miR-193a-3p mimic using EDV minicells inhibited MPM xenograft tumour growth, and was associated with increased apoptosis. In conclusion, miR-193a-3p appears to have importance in the biology of MPM and may represent a target for therapeutic intervention.
Insights
MicroRNA-193a-3p is significantly reduced in malignant pleural mesothelioma (MPM). Restoring miR-193a-3p levels inhibits MPM growth and induces cell death, suggesting its therapeutic potential for this asbestos-induced cancer.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Malignant pleural mesothelioma (MPM) is an aggressive cancer linked to asbestos exposure.
- Altered microRNA (miRNA) expression is a hallmark of MPM.
- Previous studies identified specific miRNAs differentiating MPM from lung adenocarcinoma, but their functional roles remain unclear.
Purpose of the Study:
- To investigate the functional significance of reduced miR-193a-3p and miR-192 in MPM.
- To explore the therapeutic potential of miR-193a-3p in MPM.
Main Methods:
- Compared miRNA expression in normal pleura and MPM tissues.
- Transfected MPM cells with miR-193a-3p mimics in vitro.
- Assessed effects on cell growth, apoptosis, and necrosis.
- Investigated the role of MCL1 in miR-193a-3p-mediated effects.
- Utilized EDV nanomedicine for targeted delivery of miR-193a-3p mimic in vivo xenograft models.
Main Results:
- MPM tissues showed significantly reduced levels of miR-193a-3p (3.1-fold) and miR-192 (2.8-fold).
- miR-193a-3p mimic transfection inhibited MPM cell growth, induced apoptosis and necrosis in vitro.
- Growth inhibition was linked to decreased MCL1 expression, mimicked by MCL1 silencing.
- In vivo, targeted delivery of miR-193a-3p mimic suppressed tumor growth and increased apoptosis.
Conclusions:
- miR-193a-3p plays a crucial role in MPM biology.
- Restoring miR-193a-3p function holds promise as a therapeutic strategy for malignant pleural mesothelioma.
More Related Videos
Related Concept Videos
Abnormal Proliferation
MicroRNAs
MicroRNAs
Induced Pluripotent Stem Cells
Somatic...

